Asthma trials in Bosnia & Herzegovina

1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma

  Where

  Banja Luka, Doboj, Sarajevo, Siroki Brijeg, Tešanj, Tuzla

  Age

  18 years to 75 years

  People

  780 worldwide

  Run by

  Chiesi Farmaceutici S.p.A.

  See details and how to joinNCT07301736 · EU 2025-521456-35-00